AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35049505 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART4MD
Number of subjects: 151
Study 35049505 — intervention group
Group type: EXPERIMENTAL
Intervention: TV-AssistDem
Number of subjects: 151
Study 35049505 — intervention group
Group type: COMPARATOR
Intervention: Living alone
Number of subjects: 151
Study 35049505 — intervention group
Group type: COMPARATOR
Intervention: Technophilia
Number of subjects: 151
Study 35049505 — intervention group
Group type: COMPARATOR
Intervention: ICTs (television and smartphone)
Number of subjects: 151
Study 33671260 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxins + HP
Number of subjects: 360
Study 33671260 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxins + XL
Number of subjects: 360
Study 33671260 — intervention group
Group type: COMPARATOR
Intervention: Toxins
Number of subjects: 360
Study 32492377 — intervention group
Group type: EXPERIMENTAL
Intervention: CSP with submucosal injection (CSP-SI)
Number of subjects: 214
Study 32492377 — intervention group
Group type: COMPARATOR
Intervention: Conventional cold snare polypectomy (C-CSP)
Number of subjects: 214
Study 33026895 — intervention group
Group type: EXPERIMENTAL
Intervention: AOT plus BCI-FES
Number of subjects: 26
Study 33026895 — intervention group
Group type: COMPARATOR
Intervention: Control (FES treatment and conventional physical therapy)
Number of subjects: 26
Study 34966761 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX + AZA
Number of subjects: 172
Study 34966761 — intervention group
Group type: COMPARATOR
Intervention: AZA
Number of subjects: 172
Study 34979180 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment (n = 318)
Number of subjects: 642
Study 34979180 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 324)
Number of subjects: 642
Study 34311135 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei rhamnosus (LGG)
Number of subjects: 30
Study 34311135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33027431 — intervention group
Group type: EXPERIMENTAL
Intervention: High adherence to the BALANCE Program
Number of subjects: 1160
Study 33027431 — intervention group
Group type: EXPERIMENTAL
Intervention: All 24-hour dietary recalls (24HR) analyzed
Number of subjects: 1160
Study 33027431 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest tertile of adherence
Number of subjects: 1160
Study 33027431 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy versus unhealthy foods
Number of subjects: 1160
Study 36107590 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial electrotherapy stimulation (CES) for 20 minutes on the day before and on the morning of surgery
Number of subjects: 80
Study 36107590 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.07 mg/kg) intramuscularly injected 30 minutes before general anesthesia
Number of subjects: 80
Study 36107590 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial electrotherapy stimulation (CES)
Number of subjects: 80
Study 36107590 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.07 mg/kg)
Number of subjects: 80
Study 32971314 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation cognitive therapy (CT)
Number of subjects: 290
Study 32971314 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 290
Study 32971314 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 290
Study 32971314 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute-phase cognitive therapy (CT)
Number of subjects: 290
Study 32967726 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolyte supplementation (Magnesium, Calcium, and Potassium) with intravenous normal saline
Number of subjects: 99
Study 32967726 — intervention group
Group type: COMPARATOR
Intervention: Normal saline alone (control group)
Number of subjects: 99
Study 32967726 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolyte supplementation
Number of subjects: 99
Study 36263238 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium intubation dosages based on Lean Body Weight (LBW) in Group 1 LBW
Number of subjects: 3
Study 36263238 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving 0.6 mg/kg rocuronium based on Total Body Weight (TBW) in Group 1K
Number of subjects: 3
Study 33137547 — intervention group
Group type: EXPERIMENTAL
Intervention: QUiPP app intervention (decision and communication tool)
Number of subjects: 202
Study 33137547 — intervention group
Group type: COMPARATOR
Intervention: Control (normal practice)
Number of subjects: 202
Study 35570929 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab maintenance therapy (AVE group)
Number of subjects: 0
Study 35570929 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (CON group)
Number of subjects: 0
Study 35074637 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking discarded cigarettes
Number of subjects: 1936
Study 35074637 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger smokers, men, smokers with lower incomes, and those who were not employed
Number of subjects: 1936
Study 35074637 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmet social needs (transportation, food, housing, physical safety, neighborhood safety)
Number of subjects: 1936
Study 35074637 — intervention group
Group type: EXPERIMENTAL
Intervention: Living with other smokers
Number of subjects: 1936
Study 35074637 — intervention group
Group type: EXPERIMENTAL
Intervention: Worse mental health
Number of subjects: 1936
Study 35074637 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater perceived stress
Number of subjects: 1936
Study 35074637 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavier smoking
Number of subjects: 1936
Study 35074637 — intervention group
Group type: EXPERIMENTAL
Intervention: Using other tobacco products
Number of subjects: 1936
Study 35074637 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumming cigarettes from others
Number of subjects: 1936
Study 35074637 — intervention group
Group type: EXPERIMENTAL
Intervention: Income, social environment, and other smoking behaviors
Number of subjects: 1936
Study 32828934 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-strand hamstring grafts
Number of subjects: 64
Study 32828934 — intervention group
Group type: COMPARATOR
Intervention: 4-strand hamstring grafts
Number of subjects: 64
Study 33748529 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic vibrotactile stimulation (SVS) mattress: specially‐constructed SVS crib mattress that delivers gentle vibrations (30–60 Hz, 12 μm RMS surface displacement) at 3‐hr intervals
Number of subjects: 230
Study 33748529 — intervention group
Group type: COMPARATOR
Intervention: Control mattress (treatment as usual; TAU): non‐oscillating hospital‐crib mattress
Number of subjects: 230
Study 33748529 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic vibrotactile stimulation (SVS) mattress
Number of subjects: 230
Study 33748529 — intervention group
Group type: COMPARATOR
Intervention: Control mattress (treatment as usual; TAU)
Number of subjects: 230
Study 32326956 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive support of labour with one-to-one midwife support, amniotomy and/or oxytocin stimulation if no progression during the next 1-2 hours.
Number of subjects: 0
Study 32326956 — intervention group
Group type: COMPARATOR
Intervention: Standard support of labour following standard procedures: Expectance until established regular contractions and 4-5 cm cervical dilatation, then one-to-one midwife support.
Number of subjects: 0
Study 33992072 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategies for promoting physical activity (mother’s physical activity groups, home‐based physical activity programs, awareness‐raising)
Number of subjects: 20
Study 33992072 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategies to reduce screen time (screen time tracker apps, increasing social connections, awareness‐raising)
Number of subjects: 20
Study 32595082 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic polypharmacy (two or more co-prescribed antipsychotic drugs)
Number of subjects: 24239
Study 32595082 — intervention group
Group type: COMPARATOR
Intervention: Antipsychotic monotherapy
Number of subjects: 24239
Study 35793815 — intervention group
Group type: COMPARATOR
Intervention: Intra-aortic balloon pump
Number of subjects: 0
Study 35793815 — intervention group
Group type: COMPARATOR
Intervention: TandemHeart and Impella devices
Number of subjects: 0
Study 35793815 — intervention group
Group type: EXPERIMENTAL
Intervention: Venoarterial extracorporeal membrane oxygenation
Number of subjects: 0
Study 33706831 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary diversity scores (DDS) at 6-8 months
Number of subjects: 385
Study 33706831 — intervention group
Group type: EXPERIMENTAL
Intervention: Not ill at 6-8 months
Number of subjects: 385
Study 33706831 — intervention group
Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 385
Study 33706831 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal/caregiver nutritional education intervention
Number of subjects: 385
Study 32768394 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training with whole-body vibration (WBV)
Number of subjects: 0
Study 32768394 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training without whole-body vibration (WBV)
Number of subjects: 0
Study 32768394 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (aerobic training with and without WBV)
Number of subjects: 0
Study 35253776 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Medication Review (SMR)
Number of subjects: 202
Study 35253776 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 202
Study 33412562 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA)
Number of subjects: 300
Study 33412562 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant Medication Management (MEDS)
Number of subjects: 300
Study 35606223 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Intervention (SI)
Number of subjects: 70
Study 35606223 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Intervention (GI)
Number of subjects: 70
Study 35606223 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Intervention (II)
Number of subjects: 70
Study 33092897 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii training in addition to traditional therapy
Number of subjects: 30
Study 33092897 — intervention group
Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 30
Study 34582775 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive management
Number of subjects: 388
Study 34582775 — intervention group
Group type: COMPARATOR
Intervention: Moderate ischemia (reference)
Number of subjects: 388
Study 36126144 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 164
Study 36126144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 34792482 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-Coated Balloon (DCB)
Number of subjects: 120
Study 34792482 — intervention group
Group type: COMPARATOR
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 120
Study 33492254 — intervention group
Group type: EXPERIMENTAL
Intervention: Two suture anchors for refixation
Number of subjects: 31
Study 33492254 — intervention group
Group type: COMPARATOR
Intervention: One suture anchor for refixation
Number of subjects: 31
Study 33109663 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodinated oil injection (OSCM group, oil-soluble contrast media)
Number of subjects: 1040
Study 33109663 — intervention group
Group type: COMPARATOR
Intervention: Ioversol injection (WSCM group, water-soluble contrast media)
Number of subjects: 1040
Study 33109663 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodinated oil injection (OSCM group)
Number of subjects: 1040
Study 35215501 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements based on L-Theanine and Vitamin B6
Number of subjects: 34
Study 35215501 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 34
Study 34216833 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 minutes of postprandial interval walking after meals
Number of subjects: 14
Study 34216833 — intervention group
Group type: COMPARATOR
Intervention: Control period (no exercise)
Number of subjects: 14
Study 34087745 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (QTP)
Number of subjects: 391
Study 34087745 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol (DRO)
Number of subjects: 391
Study 34087745 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofexidine + Dronabinol (LFD)
Number of subjects: 391
Study 34087745 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 391
Study 33290307 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccadic Vector Optokinetic Perimetry (SVOP)
Number of subjects: 97
Study 33290307 — intervention group
Group type: COMPARATOR
Intervention: Standard Automated Perimetry (SAP)
Number of subjects: 97
Study 33290307 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related sensitivity decrease
Number of subjects: 97
Study 36429975 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal strength intervention
Number of subjects: 40
Study 36429975 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal flexibility intervention
Number of subjects: 40
Study 36429975 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal flexibility intervention (females)
Number of subjects: 40
Study 36429975 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal flexibility intervention (males)
Number of subjects: 40
Study 35073989 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 + 1 schedule (one dose at 6 weeks and a booster at 9 months)
Number of subjects: 68
Study 35073989 — intervention group
Group type: COMPARATOR
Intervention: 3 + 0 schedule (three doses at 6, 10, and 14 weeks)
Number of subjects: 68
Study 35073989 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 + 1 schedule
Number of subjects: 68
Study 35977025 — intervention group
Group type: EXPERIMENTAL
Intervention: AMY-101
Number of subjects: 31
Study 35977025 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 33783399 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin 36 IU (3 sprays) twice a day
Number of subjects: 62
Study 33783399 — intervention group
Group type: COMPARATOR
Intervention: Intranasal placebo-oxytocin (3 sprays) twice a day
Number of subjects: 62
Study 32750332 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) nasal spray
Number of subjects: 94
Study 32750332 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) nasal spray
Number of subjects: 94
Study 36399342 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard message group
Number of subjects: 945
Study 36399342 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored message group
Number of subjects: 945
Study 36399342 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 945
Study 32162943 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week intervention designed to increase relationship maintenance in marriage
Number of subjects: 60
Study 32162943 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater relationship maintenance from spouses
Number of subjects: 60
Study 32162943 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater relationship maintenance for wives
Number of subjects: 60
Study 32162943 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater relationship maintenance for fathers
Number of subjects: 60
Study 32162943 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week intervention
Number of subjects: 60
Study 34841461 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised high‐intensity interval training during NACRT followed by unsupervised continuous exercise after NACRT
Number of subjects: 36
Study 34841461 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study 34444881 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GF) with varying sucrose concentrations
Number of subjects: 148
Study 34444881 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable broth (VB) with varying sodium chloride concentrations
Number of subjects: 148
Study 34444881 — intervention group
Group type: EXPERIMENTAL
Intervention: Food choice, familiarity, stated liking, and neophobia questionnaires
Number of subjects: 148
Study 32926462 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib (2 mg)
Number of subjects: 2531
Study 32926462 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib (4 mg)
Number of subjects: 2531
Study 32926462 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib (all doses)
Number of subjects: 2531
Study 32926462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2531
Study 32209490 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led learning group (n = 34)
Number of subjects: 102
Study 32209490 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentorship-led group (n = 34)
Number of subjects: 102
Study 32209490 — intervention group
Group type: COMPARATOR
Intervention: Faculty-led control group (n = 34)
Number of subjects: 102
Study 33057858 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 0
Study 33057858 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32203810 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative air ions (NAI)
Number of subjects: 44
Study 32203810 — intervention group
Group type: EXPERIMENTAL
Intervention: Particulate matter (PM) reduction
Number of subjects: 44
Study 36370636 — intervention group
Group type: EXPERIMENTAL
Intervention: Tampax Menstrual Cup
Number of subjects: 65
Study 36370636 — intervention group
Group type: COMPARATOR
Intervention: Another menstrual cup
Number of subjects: 65
Study 32930621 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief self-exercise education (brief-See)
Number of subjects: 0
Study 32930621 — intervention group
Group type: COMPARATOR
Intervention: Material-based education alone
Number of subjects: 0
Study 32586302 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries-free children (case group)
Number of subjects: 500
Study 32586302 — intervention group
Group type: COMPARATOR
Intervention: Children with dental caries (control group)
Number of subjects: 500
Study 36069322 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine follow-up
Number of subjects: 123
Study 36069322 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face follow-up
Number of subjects: 123
Study 33872417 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Nurse Practitioner-led training programme (1-hour training session on self-measurement of blood pressure)
Number of subjects: 170
Study 33872417 — intervention group
Group type: COMPARATOR
Intervention: Usual care (written and verbal information on HBPM recommendations)
Number of subjects: 170
Study 35943120 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranger drug‐coated balloon (DCB)
Number of subjects: 129
Study 34032934 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized pharmaceutical plan with a 30-min opioid-targeted pharmaceutical interview
Number of subjects: 35
Study 34032934 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 35
Study 35538479 — intervention group
Group type: EXPERIMENTAL
Intervention: E2/NOMAC (1.5 mg 17β-estradiol + 2.5 mg nomegestrol acetate)
Number of subjects: 197
Study 35538479 — intervention group
Group type: EXPERIMENTAL
Intervention: DNG (2 mg/daily dienogest)
Number of subjects: 197
Study 32101302 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin Self-monitoring (SSM) smartphone application with monthly self-monitoring reminders
Number of subjects: 238
Study 32101302 — intervention group
Group type: COMPARATOR
Intervention: Standard written advice on sun protection and skin cancer detection
Number of subjects: 238
Study 32101302 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin Self-monitoring (SSM) smartphone application
Number of subjects: 238
Study 35043716 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus Aspirin 100 mg once daily
Number of subjects: 88
Study 35043716 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg once daily
Number of subjects: 88
Study 32114641 — intervention group
Group type: EXPERIMENTAL
Intervention: High polyphenols (PP) diet
Number of subjects: 78
Study 32114641 — intervention group
Group type: EXPERIMENTAL
Intervention: High long-chain n-3 polyunsaturated fatty acids (LCn3) diet
Number of subjects: 78
Study 32114641 — intervention group
Group type: COMPARATOR
Intervention: Low LCn3 and PP diet
Number of subjects: 78
Study 32114641 — intervention group
Group type: EXPERIMENTAL
Intervention: High LCn3 and PP diet
Number of subjects: 78
Study 36028272 — intervention group
Group type: EXPERIMENTAL
Intervention: Community influencer groups intervention
Number of subjects: 632
Study 36028272 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 632
Study 34762673 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health First Aid training, mental health awareness session, confidential staff peer support service
Number of subjects: 1722
Study 34762673 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 1722
Study 33720967 — intervention group
Group type: EXPERIMENTAL
Intervention: Children who smoke
Number of subjects: 646
Study 33720967 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with a role as a family member
Number of subjects: 646
Study 33720967 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who use alcohol
Number of subjects: 646
Study 33720967 — intervention group
Group type: EXPERIMENTAL
Intervention: Women living in a family with financial problems
Number of subjects: 646
Study 33720967 — intervention group
Group type: EXPERIMENTAL
Intervention: Women living with a family member who uses alcohol
Number of subjects: 646
Study 33720967 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly who use alcohol
Number of subjects: 646
Study 33720967 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly living with a family member who uses alcohol
Number of subjects: 646
Study 33720967 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly living in a family with financial problems
Number of subjects: 646
Study 32739072 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hygiene program combined with home-phone health promoting counseling
Number of subjects: 136